The essential oils from Melissa officinalis L. and Lavandula angustifolia Mill. as potential treatment for agitation in people with severe dementia

International Journal of Essential Oil Therapeutics

Volumn 1, Issue 4, 2007, Pages 143-152

  Elliott, M S J ^a   Abuhamdah, S ^b   Howes, M J R ^c   Lees, G ^d   Ballard, C G ^a   Holmes, C ^e   Burns, A ^f   Chazot, P L ^b   Perry, E K ^a   Francis, P T ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

^c JODRELL LABORATORY   (United Kingdom)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Agitation; Aromatherapy; Dementia; Essential oils; Lavandula angustifolia; Lavender; Melissa; Melissa officinalis

Indexed keywords

1 OCTEN 3 YL ACETATE; 4 AMINOBUTYRIC ACID A RECEPTOR; BETA FARNESENE; BORNEOL; CARYOPHYLLENE; CARYOPHYLLENE OXIDE; CINEOLE; CITRONELLOL; ESSENTIAL OIL; G PROTEIN COUPLED RECEPTOR; GERANIC ACID; GERANIOL; GERANYL ACETATE; GERMACRENE D; HISTAMINE H3 RECEPTOR; LAVANDULOL; LAVANDULYL ACETATE; LINALOOL; LINALYL ACETATE; MUSCARINIC M1 RECEPTOR; NEROL; OCIMENE; RADIOLIGAND; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; TERPINEN 4 OL; UNCLASSIFIED DRUG;

AGITATION; ANIMAL TISSUE; AROMATHERAPY; ARTICLE; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMENTIA; DRUG POTENCY; DRUG RECEPTOR BINDING; LAVANDULA ANGUSTIFOLIA; MALE; MASS FRAGMENTOGRAPHY; MEDICINAL PLANT; MELISSA OFFICINALIS; NONHUMAN; RAT;

EID: 39149143631     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ballard C, Gray A, Ayre G. Psychotic symptoms, aggression and restlessness in dementia. Rev Neurol. 1999;155 Suppl 4:S44-S52.
2. Ballard C, Waite G. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Sys Rev. 2006;25(1):CD003476.
3. Ballard C, Howard R. Neuroleptic drugs in dementia:benefits and harm. Nat Rev Neurosci. 2006;7:492-500.
4. Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors. Focus on newer generation compounds. Life Sci. 2000;68:29-39.
5. Yamada K,MimakiY,SashidaY.Anticonvulsive effects of inhaling lavender oil vapour. Biol Pharm Bull. 1994;17:359-60.
6. Umezu T. Behavioural effects of plant-derived essential oils in the Gellar types conflict test in mice. Jpn J Pharmacol. 2000;83:150-3.
7. Buchbauer G, Jirovetz L, Jager W, Plank C, Dietrich H. Fragrance compounds and essential oils with sedative effects upon inhalation. J Pharm Sci. 1993;82:660-4.
8. Buchbauer G, Jirovetz L, Jager W. Aromatherapy: evidence for sedative effects of the essential oil of lavender after inhalation. Z Naturforsch. 1991;46c:1067-72.
9. Umezu T, Nagano K, Ito H, Kosakai K, Sakaniwa M, Morita M. Anticonflict effects of lavender oil and identification of its active constituents. Pharmacol Biochem Behav. 2006;85:713-21.
10. Kennedy DO, Scholey AB, Tildesley NTJ, Perry EK, Wesnes KA. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav. 2002;72:953-64.
11. Kennedy DO, Little W, Scholey AB.Attenuation of laboratory induced stress in humans following acute administration of Melissa officinalis (lemon balm). Psychosom Med. 2004;66:607-13.
12. Smallwood J, Brown R, Coulter F, Irvine E, Copland C. Aromatherapy and behaviour disturbances in dementia: a randomised controlled trial. Int J Geriatr Psychiatry. 2001;16:1010-13.
13. Ballard CG, O'Brien CT, Reichelt K, Perry EK.Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with melissa. J Clin Psychiatry. 2002;63:553-8.
14. Holmes C, Hopkins V, Hensford C, MacLaughlin V, Wilkinson D, Rosenvinge V. Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study. Int J Geriatr Psychiatry. 2002;17:305-8.
15. Lin PWK, Chan WC, Ng BFL, Lam LCW. Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: a cross-over randomised trial. Int J Geriatr Psychol. 2007;22:405-10.
16. British Pharmacopoeia, Volume I. London: The Stationery Office; 2002.
17. Silva Brum LF, Emanuelli T, Souza DO, Elisabetsky E. Effects of linalool on glutamate release and uptake in mouse cortical synaptosomes. Neurochem Res. 2001;26:191-4.
18. Wichtl M. (Ed.) Herbal drugs and phytopharmaceuticals (3rd Ed.). Stuttgart: MedPharm Scientific Publishers; 2004.
19. Aoshima H, Hamamoto K. Potentiation of GABAA receptors expressed in Xenopus oocytes by perfume and phytoncid. Biosci Biotechnol Biochem. 1999;63:743-8.
20. Sachdev P, Kruk J. Restlessness: the anatomy of a neuropsychiatric symptom. Aust NZ J Psychiatry. 1996;30:38-53.
21. Lindenmayer JP. The pathophysiology of agitation. J Clin Psychiatry. 2000;61(suppl 14):5-10.
22. Davies NW. Gas-chromatographic retention indexes of monoterpenes and sesquiterpenes on methyl silicone and carbowax 20M phases. J Chromatogr. 1990;503(1):1-24.
23. Ausloos P, Clifton C, Lias SG, Shamin A, Stein S. NIST/EPA/NIH Mass spectral database (v. 4.0). Gaitherburg, USA: US Department of Commerce; 1992.
24. Adams RP. Identification of essential oil components by gas chromatography / quadrupole mass spectroscopy. Illinois, USA:Allured Publishing Corporation; 2001.
25. Perry E, Perry N. Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives. CNS Drugs. 2006;20:257-80.
26. van den Berg T, Freundl E, Czygan F-C. Melissa officinalis subsp. altissima: Characteristics of a possible adulteration of lemon balm. Pharmazie. 1997;52:802-8.
27. Mimica-Dukic N, Bozin B, Sokovic M, Simin N. Antimicrobial and antioxidant activities of Melissa officinalis L. (Lamiaceae) essential oil. J Agric Food Chem. 2004;52:2485-9.
28. Meyer W, Spiteller G. Increase of caryophyllene oxide in ageing lemon balm leaves (Melissa officinalis L.) - A consequence of lipid peroxidation? Z Naturforsch [C]. 1996;51:651-6.
29. Mrlianova M, Tekel'ova D, Felklova M, Reinöhl V, Toth J. The influence of the harvest cut height on the quality of the herbal drugs melissae folium and melissae herba. Planta Med. 2001;67:178-80.
30. Adzet T, Ponz R, Wolf E, Schulte E. Content and composition of M. officinalis oil in relation to leaf position and harvest time. Planta Med. 1992;58:562-4.
31. Şarer E, Kökdil G. Constituents of the essential oil from Melissa officinalis. Planta Med. 1991;57:89-91.
32. Kovar KA, Gropper B, Friess D, Ammon HPT. Blood levels of 1,8-cineole and locomotor activity of mice after inhalation and oral administration of rosemary oil. Planta Med. 1987;53:315-8.
33. Jirovetz L, Buchbauer G, Jager W, Raverdino V, Nikiforov A. Determination of lavender oil fragrance compounds in blood samples. Fresenius J Anal Chem. 1990;338:922-3.
34. Cal K. Skin penetration of terpenes from essential oils and topical vehicles. Planta Med. 2006;72:311-6.
35. Cal K, Krzyzaniak M. Stratum corneum absorption and retention of linalool and terpinen-4-ol applied as a gel or oily solution in humans. J Dermatol Sci. 2006;42:265-7.
36. Higaki K, Amnuaikit C, Kimura T. Strategies for overcoming the stratum corneum: chemical and physical approaches. Am J Drug Deliv. 2003;1:187-214.
37. Frey WH. Intranasal delivery: Bypassing the blood-brain barrier to deliver therapeutic agents to the brain and spinal cord. Drug Deliv Tech. 2002;2:46-9.
38. Sieghart W. Structure, pharmacology and function of GABAA receptor subtypes. Adv Pharmacol. 2006;54:231-63.